INE406M01024
INE406M01024
ERIS LIFESCIENCES LIMITED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 162.42B EUR | 198.56B EUR | 179.72B EUR | 205.11B EUR |
Enterprise Value | 185B EUR | 198.56B EUR | 202.76B EUR | 205.11B EUR |
Valuation Multiples | ||||
Trailing P/E | 24.93x | 30.84x | 29.01x | 60.7x |
Forward P/E | 20.29x | -- | -- | -- |
Price to Sales | 5.06x | 6.18x | 5.77x | 8.68x |
Price to Book | 4.1x | -- | 4.6x | -- |
EV/Revenue | 5.76x | 6.18x | 6.51x | 8.68x |
EV/EBITDA | 16.34x | 17.33x | 17.98x | 24.04x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |